BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17003815)

  • 1. Vasopressin administration facilitates fluid removal during hemodialysis.
    van der Zee S; Thompson A; Zimmerman R; Lin J; Huan Y; Braskett M; Sciacca RR; Landry DW; Oliver JA
    Kidney Int; 2007 Feb; 71(4):318-24. PubMed ID: 17003815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis.
    Fasanella d'Amore T; Wauters JP; Waeber B; Nussberger J; Brunner HR
    Clin Nephrol; 1985 Jun; 23(6):299-302. PubMed ID: 4028528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intranasal DDAVP in prevention of hypotension during hemodialysis.
    Beladi-Mousavi SS; Beladi-Mousavi M; Hayati F; Talebzadeh M
    Nefrologia; 2012; 32(1):89-93. PubMed ID: 22294007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous and exogenous vasopressin during hemodialysis.
    Thompson AM; Oliver JA
    Semin Dial; 2009; 22(5):472-5. PubMed ID: 19522759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin in end-stage renal disease: relationship to salt, catecholamines and renin activity.
    Papadoliopoulou-Diamandopoulou N; Papagalanis N; Gavras I; Gavras H
    Clin Exp Hypertens A; 1987; 9(7):1197-208. PubMed ID: 3304733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study.
    Ettema EM; Kuipers J; van Faassen M; Groen H; van Roon AM; Lefrandt JD; Westerhuis R; Kema IP; van Goor H; Gansevoort RT; Gaillard CAJM; Franssen CFM
    BMC Nephrol; 2018 Aug; 19(1):214. PubMed ID: 30134847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of plasma vasopressin in patients undergoing chronic hemodialysis.
    Shimamoto K; Watarai I; Miyahara M
    J Clin Endocrinol Metab; 1977 Oct; 45(4):714-20. PubMed ID: 914976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperosmolality on vasopressin secretion in intradialytic hypotension: a mechanistic study.
    Shimizu K; Kurosawa T; Sanjo T
    Am J Kidney Dis; 2008 Aug; 52(2):294-304. PubMed ID: 18562062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin secretion by hypertonic saline infusion during hemodialysis: effect of cardiopulmonary recirculation.
    Shimizu K; Kurosawa T; Ishikawa R; Sanjo T
    Nephrol Dial Transplant; 2012 Feb; 27(2):796-803. PubMed ID: 21633094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressor response to fluid resuscitation in endotoxic shock: involvement of vasopressin.
    Batista MB; Bravin AC; Lopes LM; Gerenuti E; Elias LL; Antunes-Rodrigues J; Giusti-Paiva A
    Crit Care Med; 2009 Nov; 37(11):2968-72. PubMed ID: 19770747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of sodium profiling on blood volume and intradialytic hypotension in patients on maintenance hemodialysis.
    Kaczmarczyk I; Kraśniak A; Drozdz M; Chowaniec E; Gajda M; Radziszewski A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):476-82. PubMed ID: 18409348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system.
    Manlucu J; Gallo K; Heidenheim PA; Lindsay RM
    Am J Kidney Dis; 2010 Jul; 56(1):69-76. PubMed ID: 20303632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension.
    Lindberg JS; Copley JB; Melton K; Wade CE; Abrams J; Goode D
    Am J Nephrol; 1990; 10(4):269-75. PubMed ID: 2240053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive method for preventing intradialytic hypotension: A pilot study.
    Saxena A; Sharma RK; Gupta A; John MM
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):896-905. PubMed ID: 26354560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
    Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
    Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hemodialysis on the plasma levels of the atrial natriuretic factor in chronic renal failure.
    Larochelle P; Béroniade V; Gutkowska J; Cusson JR; Lécrivain A; du Souich P; Cantin M; Genest J
    Clin Invest Med; 1987 Jul; 10(4):350-4. PubMed ID: 2958203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the plasma concentration of antidiuretic hormone in chronic renal insufficiency during hemodialysis].
    Horký K; Srámková J; Lachmanová J; Tomásek R; Dvoráková J
    Cas Lek Cesk; 1977 Nov; 116(47):1449-55. PubMed ID: 597830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.